Heart [310] — Athena

: Periodic testing is recommended due to reported cases of liver injury.

: Contraindicated in patients with symptomatic heart failure or recent hospitalization for heart failure (NYHA Class IV or symptomatic Class II-III).

Monitor closely if the patient is also taking warfarin, as dronedarone can increase warfarin exposure. 4. Patient Monitoring ATHENA HEART [310]

Stop other Class I or III antiarrhythmics (e.g., amiodarone, sotalol) before starting Multaq. Avoid strong (e.g., ketoconazole).

: To determine if dronedarone could lower the risk of hospitalization due to cardiovascular events or death from any cause in patients with atrial fibrillation (AF) or atrial flutter (AFL). : Periodic testing is recommended due to reported

The official FDA label outlines critical safety measures based on ATHENA data: :

One tablet should be taken with the and one with the evening meal to ensure proper absorption. Target Population : : To determine if dronedarone could lower the

Clinicians should monitor several factors to prevent adverse outcomes: